• 2449 Citations
20082022
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Training Experience

2003Residency, Royal College of Physicians, Ireland
2009Fellowship, University of Texas Health Science Center, San Antonio
2009Fellowship, Royal College of Physicians, Ireland

Education/Academic qualification

PhD, National University of Ireland

… → 2009

MBBChBAO, National University of Ireland

… → 2000

Fingerprint Dive into the research topics where Devalingam Mahalingam is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles
Neoplasms Medicine & Life Sciences
Apoptosis Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Prostatic Neoplasms Medicine & Life Sciences
Safety Medicine & Life Sciences
TNF-Related Apoptosis-Inducing Ligand Receptors Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2017 2022

Research Output 2008 2019

4 Citations (Scopus)

A phase II, multicenter, single-arm study of mipsagargin (G-202) as a second-line therapy following sorafenib for adult patients with progressive advanced hepatocellular carcinoma

Mahalingam, D., Peguero, J., Cen, P., Arora, S. P., Sarantopoulos, J., Rowe, J., Allgood, V., Tubb, B. & Campos, L., Jun 1 2019, In : Cancers. 11, 6, 833.

Research output: Contribution to journalArticle

Open Access
Hepatocellular Carcinoma
Disease-Free Survival
Disease Progression
Neoplasms
Magnetic Resonance Imaging
Open Access
Hepatocellular Carcinoma
Liver
Therapeutics
Protein-Tyrosine Kinases
Immunotherapy

Docetaxel, Oxaliplatin, and 5-Fluorouracil (DOF) in Metastatic and Unresectable Gastric/Gastroesophageal Junction Adenocarcinoma: A Phase II Study with Long-Term Follow-Up

Rosenberg, A. J., Rademaker, A. W., Hochster, H. S., Ryan, T., Hensing, T., Shankaran, V., Baddi, L., Mahalingam, D., Mulcahy, M. F. & Benson III, A. B., Jan 1 2019, In : Oncologist. 24, 8, p. 1039-e642

Research output: Contribution to journalArticle

oxaliplatin
docetaxel
Esophagogastric Junction
Fluorouracil
Stomach

Heightened JNK activation and reduced XIAP levels promote TRAIL and sunitinib-mediated apoptosis in colon cancer models

Mahalingam, D., Carew, J. S., Espitia, C. M., Cool, R. H., Giles, F. J., De Jong, S. & Nawrocki, S. T., Jul 1 2019, In : Cancers. 11, 7, 895.

Research output: Contribution to journalArticle

Open Access
X-Linked Inhibitor of Apoptosis Protein
Colonic Neoplasms
Phosphotransferases
Apoptosis
Neoplasms
1 Citation (Scopus)

Nivolumab in Metastatic Adrenocortical Carcinoma: Results of a Phase 2 Trial

Carneiro, B. A., Konda, B., Costa, R. B., Costa, R. L. B., Sagar, V., Gursel, D. B., Kirschner, L. S., Chae, Y. K., Abdulkadir, S. A., Rademaker, A., Mahalingam, D., Shah, M. H. & Giles, F. J., Dec 1 2019, In : The Journal of clinical endocrinology and metabolism. 104, 12, p. 6193-6200 8 p.

Research output: Contribution to journalArticle

Adrenocortical Carcinoma
Chemotherapy
Mitotane
Drug Therapy
Disease-Free Survival